Human Cortico-Spinal-Muscle Assembloids for Motor Circuit Modeling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack effective human models for translating therapies targeting the corticospinal tract circuit, which is crucial for motor function, due to the inability to functionally integrate components of this circuit in vitro, hindering the development of treatments for spinal cord injuries and neurodegenerative disorders like ALS and MS.
Innovation Solution
The generation of functional human cortico-spinal-muscle assembled spheroids from human pluripotent stem cells, which include ventral spinal cord and skeletal muscle cells, allowing for the formation of neuromuscular junctions and integration of cortical neurons, enabling the analysis and screening of therapeutic agents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If human pluripotent stem cells are differentiated into separate neural and muscle cell cultures, then cell purity and functional specificity are improved, but the ability to model integrated corticospinal tract circuitry deteriorates
Solution Approach 1:
The patent combines separate neural culture systems and muscle culture systems into integrated 3D assembloid structures. Cortical spheroids containing layer-specific neurons are merged with spinal cord spheroids and skeletal muscle spheroids to create hCS-hSC-hSkM assembloids that preserve cell-type specificity while enabling functional circuit integration across previously separate systems.
Solution Approach 2:
The patent implements a hierarchical nesting structure where cortical spheroids (hCS) containing multiple cortical layers are nested with spinal cord spheroids (hSC), which are in turn nested with or adjacent to skeletal muscle spheroids (hSkM). This nested arrangement allows each cell type to maintain its specialized function while being positioned within the integrated 3D circuit architecture.
2Productivity
If animal models are used to study corticospinal tract disorders, then research progress is improved, but translatability to human treatments deteriorates
Solution Approach 1:
The patent creates human-specific in vitro copies of the corticospinal tract circuit using human pluripotent stem cells. The hCS-hSC-hSkM assembloids replicate the essential functional components (cortical neurons, spinal motor neurons, and skeletal muscle) and their interconnections, providing a human-relevant model that copies the key features of the in vivo circuit without requiring animal subjects.
3Productivity
If simple cell cultures are used for drug screening, then screening efficiency is improved, but physiological relevance deteriorates
Solution Approach 1:
The patent transforms traditional 2D cell culture parameters into 3D Assembloid structures with altered physical and functional parameters. The 3D architecture, cell-cell contact geometry, and emergent circuit-level functions create a more physiological environment while maintaining high-throughput screening capability through standardized assembly protocols and readout methods.
Data Source
AI summary
Functional human cortico-spinal-muscle assembled spheroids are generated by in vitro culture. Complete cortico-spinal-muscle spheroids (hCS-hSC-hSkM) are assembled from component cultured cell systems, where each cultured cell system is designed to provide specific sets of neural and/or muscle cells, and which components are functionally integrated in the assembled spheroid.